787 | Thanks | mwirmm | 11/15/2012 10:36:20 AM |
786 | I agree | mwirmm | 11/15/2012 10:35:14 AM |
785 | IF they | mwirmm | 11/15/2012 10:34:29 AM |
784 | Im thin | mwirmm | 11/15/2012 10:32:55 AM |
783 | I think | mwirmm | 11/15/2012 10:29:37 AM |
782 | PTS, Inc. (PTSH) to Develop "Green Energy Park" | John Howard | 11/15/2012 7:35:02 AM |
781 | i defin | John Howard | 11/15/2012 7:31:12 AM |
780 | Well lo | John Howard | 11/15/2012 7:29:11 AM |
779 | I agree | John Howard | 11/15/2012 7:26:16 AM |
778 | PR is t | John Howard | 11/15/2012 7:23:14 AM |
777 | If you | aleksdavis | 11/15/2012 6:28:53 AM |
776 | When do | theellasmith | 11/15/2012 6:28:12 AM |
775 | I think so, too. PTSH will score big in the | theellasmith | 11/15/2012 6:26:03 AM |
774 | Little push I think PTSH just needs a | aleksdavis | 11/15/2012 6:24:26 AM |
773 | Yesterd | aleksdavis | 11/15/2012 6:12:56 AM |
772 | Thats w | aleksdavis | 11/15/2012 6:09:55 AM |
771 | I belie | aleksdavis | 11/15/2012 6:07:02 AM |
770 | PTSH - | theellasmith | 11/15/2012 5:59:05 AM |
769 | PTSH - | theellasmith | 11/15/2012 5:55:05 AM |
768 | PTSH - | theellasmith | 11/15/2012 5:50:33 AM |
767 | Especiallyat this price.Once | judith keenan | 11/14/2012 1:20:37 PM |
766 | Definit | theellasmith | 11/14/2012 1:19:46 PM |
765 | I agree howard som | judith keenan | 11/14/2012 1:16:43 PM |
764 | Well, w | theellasmith | 11/14/2012 1:16:14 PM |
763 | Advice for short players! | Mary Johnson | 11/14/2012 1:14:28 PM |
762 | According to overall analysis | Mary Johnson | 11/14/2012 1:11:08 PM |
761 | I`m following your lead with Ptsh I am pretty | judith keenan | 11/14/2012 1:11:00 PM |
760 | I've se | theellasmith | 11/14/2012 1:10:23 PM |
759 | Accordi | Mary Johnson | 11/14/2012 1:08:00 PM |
758 | PTSH - | theellasmith | 11/14/2012 1:05:22 PM |
757 | Ptsh also may surprise everyone, not that | judith keenan | 11/14/2012 1:04:51 PM |
756 | You are | Mary Johnson | 11/14/2012 1:03:41 PM |
755 | time to get in, a 20% easy profit to | judith keenan | 11/14/2012 12:59:36 PM |
754 | PTSH - | theellasmith | 11/14/2012 12:59:08 PM |
753 | PTSH short term | mwirmm | 11/14/2012 8:08:25 AM |
752 | Excelle | mwirmm | 11/14/2012 8:06:21 AM |
751 | THanks | mwirmm | 11/14/2012 8:04:55 AM |
750 | Should | mwirmm | 11/14/2012 8:02:13 AM |
749 | Excelle | mwirmm | 11/14/2012 8:01:38 AM |
748 | PTSH is | John Howard | 11/14/2012 7:49:08 AM |
747 | I think | John Howard | 11/14/2012 7:46:18 AM |
746 | we defi | John Howard | 11/14/2012 7:44:14 AM |
745 | Everyth | John Howard | 11/14/2012 7:42:28 AM |
744 | Some of | aleksdavis | 11/14/2012 5:09:49 AM |
743 | GREEN+PTSH=$$$ Just to remind you that 2 weeks | Milly Joel | 11/14/2012 5:09:37 AM |
742 | Well, i | aleksdavis | 11/14/2012 5:01:05 AM |
741 | That means that all puzzle pieces are here, only | Milly Joel | 11/14/2012 4:55:49 AM |
740 | Well, we are in the middle of the trading week, | Milly Joel | 11/14/2012 4:52:25 AM |
739 | Agree.M | aleksdavis | 11/14/2012 4:51:12 AM |
738 | BULLS ARE STRONGER Yesterdays trading dynamic | Milly Joel | 11/14/2012 4:38:53 AM |
Recent Articles
- Sampo plc's Recent Share Buyback Insights and Impacts
- Strategic Alliance Between Dev4All and Pharmaseed Enhances R&D
- Rémy Cointreau Reveals Availability of Financial Report Online
- Getlink SE Faces Delays in ElecLink Operations Recovery
- Shenzhen's Transformative Influence on Global Branding and Quality
- Jiangsu's Transformation: Merging Rich History with Innovation
- Hexagon Purus ASA Reports Record Q3 Growth and Future Plans
- CTP Delivers State-of-the-Art Logistics Facility to Tesco
- Galderma's Nemolizumab Shows Promising Results for Itch Relief
- Explore Tokyo Psychodemic: An Immersive Gaming Experience
- Neos Corporation Unveils Enhanced Crayon Shin-chan App for iOS
- CoinEx Charity's Starlink Initiative Transforms Connectivity
- Zai Lab Boosts Patient Access to AUGTYRO for Lung Cancer
- Recursive Teams Up with Saudi Arabia for AI-Powered TB Solutions
- Akeso's Cadonilimab and Ivonescimab Added to National Drug List
- TeamT5 Earns Prestigious Recognitions in Cybersecurity Innovation
- Innovent Biologics Adds SINTBILO and Olverembatinib to NRDL
- Genesis Lifestyle Medicine Recognized for Stellar Leadership Achievement
- Genesis Lifestyle Medicine Earns Certified Amazing Workplace Honor
- Bridging Cultures: China and Europe's River Dialogues
- The Surge in Population Health Management: A $663.75 Billion Future
- Prime Mining Releases New Technical Report on Los Reyes Project
- Investigation Announced for Symbotic Inc. Shareholders
- Monument Mining Limited Reports Positive Q1 FY 2025 Results
- Strategic Alliance Between Sumitomo and Rikkeisoft Ignites Growth
- Innovative Approaches to Combat the Fall Armyworm Crisis
- Exro Technologies Faces Potential Class Action Suit
- BioArctic's Leqembi®: A New Hope for Alzheimer's Patients
- BioArctic Partners with Eisai for Leqembi Launch in Asia
- Rakovina Therapeutics Unveils New Financial Strategy for Growth
- Nonwoven Filtration Market Expected to Hit $8.4 Billion by 2028
- AIP Realty Trust Reports Q3 Financial Progress and Future Growth
- Weave Living and KKR Form Joint Venture to Enhance Japan's Housing Market
- Celsius Holdings Faces Legal Challenges—What Investors Should Know
- Lomiko Metals Secures Funding for La Loutre Graphite Project
- U.S. Gold Corp. Launches Significant $10.2 Million Offering
- Key Insights into the Growth of the Medical Nonwoven Market
- Exploring the Growth of the Portable Power Station Market
- Investors Alert: Class Action Update on Edwards Lifesciences
- Casio Unveils Iconic DW-5000R, A Nod to G-SHOCK Heritage
- Casio Unveils New DW-5000R, Reviving G-SHOCK's Legacy
- American Lithium's Annual Meeting Highlights and Future Plans
- Rentokil Initial PLC Faces Class Action Claims - Key Insights
- Significant Jury Victory for Guardant Health Against Natera
- Robbins LLP Highlights Class Action Opportunities for AILE Investors
- Legal Update: Dentsply Sirona Inc. Class Action Notification
- Exploring Growth within the Animal Feed Additives Industry
- Women’s Watch Market Set for Significant Growth by 2031
- Eisai and Biogen Launch LEQEMBI for Alzheimer's in New Markets
- Patterson Companies to Host Second Quarter Conference Call